ES2163441T3 - Composiciones topicas para la repitelizacion de defectos epiteliales persistentes. - Google Patents

Composiciones topicas para la repitelizacion de defectos epiteliales persistentes.

Info

Publication number
ES2163441T3
ES2163441T3 ES94915864T ES94915864T ES2163441T3 ES 2163441 T3 ES2163441 T3 ES 2163441T3 ES 94915864 T ES94915864 T ES 94915864T ES 94915864 T ES94915864 T ES 94915864T ES 2163441 T3 ES2163441 T3 ES 2163441T3
Authority
ES
Spain
Prior art keywords
repitelization
topical compositions
epithelial defects
persistent
persistent epithelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94915864T
Other languages
English (en)
Inventor
Patricia B Williams
Earl R Crouch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Application granted granted Critical
Publication of ES2163441T3 publication Critical patent/ES2163441T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Abstract

LOS EFECTOS EPITELIALES PERSISTENTES SE TRATAN EFICAZMENTE MEDIANTE LA APLICACION TOPICA DE UNA COMPOSICION GELATINOSA QUE CONTIENE UN ACIDO AMINOCAPRIOICO O TRANEXAMICO AL OJO. LOS RESULTADOS IN VIVO DEMUESTRAN UNA CICATRIZACION MEJORADA DEL EPITELIO Y DEL COMPLEJO DE LA MEMBRANA BASE. LA COMPOSICION GELATINOSA SE PREPARA MEDIANTE UN PROCESO QUE ASEGURA LA ESTERILIDAD Y LAS CONDICIONES DE PH ADECUADAS EN LA TOTALIDAD DEL GEL.
ES94915864T 1993-04-30 1994-04-25 Composiciones topicas para la repitelizacion de defectos epiteliales persistentes. Expired - Lifetime ES2163441T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5571793A 1993-04-30 1993-04-30

Publications (1)

Publication Number Publication Date
ES2163441T3 true ES2163441T3 (es) 2002-02-01

Family

ID=21999701

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94915864T Expired - Lifetime ES2163441T3 (es) 1993-04-30 1994-04-25 Composiciones topicas para la repitelizacion de defectos epiteliales persistentes.

Country Status (6)

Country Link
US (1) US5541226A (es)
EP (1) EP0711175B1 (es)
AT (1) ATE204742T1 (es)
DE (1) DE69428120T2 (es)
ES (1) ES2163441T3 (es)
WO (1) WO1994025058A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10258954A1 (de) * 2002-12-16 2004-07-08 Langer, Hans-Georg Blutungsstillende Wundversorgung
US7608074B2 (en) * 2003-01-10 2009-10-27 Smith & Nephew, Inc. External fixation apparatus and method
AU2010335066A1 (en) * 2009-12-17 2012-08-02 Don Macalister Topical oral gel formulations for dental use
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171377A (en) * 1978-08-11 1979-10-16 Burton, Parsons & Co., Inc. Ophthalmic solution of tranexamic acid
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
SE466134B (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner

Also Published As

Publication number Publication date
WO1994025058A1 (en) 1994-11-10
DE69428120D1 (de) 2001-10-04
EP0711175A1 (en) 1996-05-15
EP0711175A4 (en) 1996-01-26
ATE204742T1 (de) 2001-09-15
DE69428120T2 (de) 2002-04-11
US5541226A (en) 1996-07-30
EP0711175B1 (en) 2001-08-29

Similar Documents

Publication Publication Date Title
FI834623A (fi) Foer medicinska aendamaol avsedd vaetskeimpregnerad saordyna.
RU94040385A (ru) Композиции клиндамицина и бензоилпероксида для лечения акне, набор для приготовления композиции, способ получения композиции, способ лечения акне
DE3750793D1 (de) Verfahren zur Behandlung von Kollagen zur Erleichterung seiner Vernetzung und das so erhaltene Kollagen.
ES491224A0 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
ATE249215T1 (de) Verwendung von app-modulatoren zur herstellung eines medikamentes zur behandlung der amyloidose
JPS57500830A (es)
DK304682A (da) Vandholdigt topisk praeparat og fremgangsmaade til formindskelse af vandtab fra saadanne praeparater
ATE399563T1 (de) Extrazelluläre, gdf-5 enthaltende matrix zur induktion oder verstärkung der chondrogenese
ES2196082T3 (es) Analagos del factor de crecimiento de queratinocitos.
ATE97316T1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
ES2163441T3 (es) Composiciones topicas para la repitelizacion de defectos epiteliales persistentes.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2059688T3 (es) Derivados de aminoacidos inhibidores de enzimas, procedimiento para su preparacion, agentes que los contienen y su utilizacion.
ATE56139T1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
PT81372B (pt) Processo para a preparacao de glicopeptidos e de composicoes anti-bacterianas que os contem
TR199901486T2 (xx) Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilamino-benzoksazol bile�ikleri.
SE8801710D0 (sv) New ophtalmological composition of matter
ATE20737T1 (de) Verfahren zur herstellung von acemetacin.
ATE342062T1 (de) Angiotensin ii zur verbesserung der befruchtung
ES2062407T3 (es) Compuestos de 2-hidroxi-3-fenoxipropilamino.
DE69333547D1 (de) Therapeutische anwendungen von chimänischer organogenese
ES2042529T3 (es) Un procedimiento para preparar una composicion terapeutica combinada de un eliminador de radicales libres o inhibidor metabolico y una proteina biologicamente activa.
GT197850651A (es) Carboxilato de alfa-trifluorometil-3-fenoxi-bencilo insecticida
BE899299A (fr) Composition fongicide a base de tris ethyl phosphonate d'aluminium
ATE59144T1 (de) Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 711175

Country of ref document: ES